Eppard Elisabeth, Homann Tatjana, de la Fuente Ana, Essler Markus, Rösch Frank
Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany; and.
Institute of Nuclear Chemistry, Johannes Gutenberg University, Mainz, Germany.
J Nucl Med. 2017 Mar;58(3):432-437. doi: 10.2967/jnumed.116.177634. Epub 2017 Jan 12.
Radiolabeling of the prostate-specific membrane antigen (PSMA) inhibitor Glu-NH-CO-NH-Lys(Ahx) using the Ga chelator HBED-CC (PSMA) allows imaging of prostate cancer lesions because of high expression of PSMA in prostate carcinoma cells and in bone metastases and lymph nodes related to the disease. The aim of this work was to optimize labeling of Ga-PSMA using the efficient cation-exchange postprocessing of Ga as well as the development of a thin-layer chromatography (TLC)-based quality control system. Labeling was optimized for online ethanol-postprocessed Ga eluate investigating various parameters, such as buffer molarity (0.1-1 M), temperature (25°C-90°C), tracer amount (0.11-0.74 nmol), and labeling time. In addition, purification of the crude product was tested. For radio-TLC quality control, various mobile phases were analyzed using silica gel 60 plates and the results were validated using high-performance liquid chromatography. The most superior mobile phases were also applied on instant thin-layer chromatography (ITLC) silica gel plates. Using optimized conditions, labeling yields of more than 95% were obtained within 10 min when ethanol-based postprocessing was applied using PSMA amounts as low as 0.1 nmol. A higher precursor concentration (0.7 nmol) further increased labeling and quantitative yields to more than 98% within 5 min. In clinical routine, patient batches (>200 applications) with radiochemical purity greater than 98% and specific activities of 326 ± 20 MBq/nmol are obtained reproducibly. When TLC quality control was performed on silica gel 60 plates, 4 mobile phases with suitable separation properties and complementary R values were identified. Two systems showed equivalent separation on ITLC silica gel plates, with ITLC analysis finished within 5 min, in contrast to 20 min for the TLC system. Labeling of PSMA was optimized for cation-exchange postprocessing methods, ensuring almost quantitative labeling and high nuclide purity of final Ga-PSMA, making subsequent purification steps unnecessary. The new radio-TLC method allows quality control in a short time using a fast, reliable, low-cost method with little equipment complexity. Using this approach, the synthesis is easily adopted by automated synthesis modules.
使用镓螯合剂HBED-CC对前列腺特异性膜抗原(PSMA)抑制剂Glu-NH-CO-NH-Lys(Ahx)进行放射性标记(PSMA),由于PSMA在前列腺癌细胞以及与该疾病相关的骨转移灶和淋巴结中高表达,从而能够对前列腺癌病灶进行成像。这项工作的目的是通过高效的镓阳离子交换后处理以及开发基于薄层色谱(TLC)的质量控制系统来优化Ga-PSMA的标记。针对在线乙醇后处理的镓洗脱液,研究了各种参数(如缓冲液摩尔浓度(0.1 - 1 M)、温度(25°C - 90°C)、示踪剂用量(0.11 - 0.74 nmol)和标记时间)对标记进行了优化。此外,还测试了粗产物的纯化。对于放射性TLC质量控制,使用硅胶60板分析了各种流动相,并使用高效液相色谱对结果进行了验证。最优良的流动相也应用于即时薄层色谱(ITLC)硅胶板。在优化条件下,当使用低至0.1 nmol的PSMA量进行基于乙醇的后处理时,10分钟内标记产率超过95%。更高的前体浓度(0.7 nmol)在5分钟内进一步将标记产率和定量产率提高到98%以上。在临床常规操作中,可重复获得放射化学纯度大于98%、比活度为326 ± 20 MBq/nmol的患者批次(>200次应用)。当在硅胶60板上进行TLC质量控制时,确定了4种具有合适分离特性且R值互补的流动相。两种系统在ITLC硅胶板上显示出等效的分离效果,ITLC分析在5分钟内完成,而TLC系统则需要20分钟。针对阳离子交换后处理方法对PSMA的标记进行了优化,确保最终Ga-PSMA几乎定量标记且核素纯度高,无需后续纯化步骤。新的放射性TLC方法允许使用快速、可靠、低成本且设备复杂度低的方法在短时间内进行质量控制。采用这种方法,合成过程很容易被自动化合成模块采用。